The neurobiology of the tuberous sclerosis complex

被引:0
作者
Leah Marcotte
Peter B. Crino
机构
[1] University of Pennsylvania Medical Center,Department of Neurology and PENN Epilepsy Center
来源
NeuroMolecular Medicine | 2006年 / 8卷
关键词
Tuberous Sclerosis; Tuberous Sclerosis Complex; Tuberin; Infantile Spasm; NeuroMolecular Medicine Volume;
D O I
暂无
中图分类号
学科分类号
摘要
Tuberous sclerosis complex (TSC) is a multisystem disorder that affects numerous organ systems. Brain lesions that form during development, known as tubers, are highly associated with epilepsy, cognitive disability, and autism. Following the identification of two genes and their encoded proteins, TSC1 (hamartin) and TSC2 (tuberin), responsible for TSC, identification of several downstream protein cascades that might be affected in TSC have been discovered. Of primary importance is the mammalian target of rapamycin pathway that controls cell growth and protein synthesis. The mechanisms governing brain lesion growth have not been fully identified but likely altered regulation of the mammalian target of rapamycin cascade by hamartin and tuberin during development leads to aberrant cell growth. Secondary effects of TSC gene mutations might disrupt normal neuronal migration and cerebral cortical lamination. Numerous studies have identified changes in gene and protein expression in animal models of TSC and in human TSC brain specimens that contribute to altered brain cytoarchitecture. This review will provide an overview of the neurobiological aspects of TSC.
引用
收藏
页码:531 / 546
页数:15
相关论文
共 340 条
[71]  
Dorer D. J.(2001)Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size Cell 105 357-368
[72]  
Thiele E. A.(2004)Behavioral and cognitive aspects of tuberous sclerosis complex J. Child Neurol. 19 666-674
[73]  
Goodman M.(2001)Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis Psychol. Med. 31 1437-1446
[74]  
Lamm S. H.(1998)Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria J. Child Neurol. 13 624-628
[75]  
Engel A.(2004)Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2 J. Biol. Chem. 79 48,707-48,715
[76]  
Shepherd C. W.(2002)Cyst-like cerebral lesions in tuberous sclerosis Am. J. Med. Genet. 111 435-439
[77]  
Houser O. W.(2004)Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase Proc. Natl. Acad. Sci. USA 101 13,489-13,494
[78]  
Gomez M. R.(2005)Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex Eur. J. Hum. Genet. 13 731-741
[79]  
Griffiths P. D.(2003)Rheb promotes cell growth as a component of the insulin/TOR signalling network Nat. Cell Biol. 5 566-571
[80]  
Bolton P.(2004)Subependymal Giant Cell Astrocytoma-a Clinicopathological Study of 23 Cases with Special Emphasis on Histogenesis Pathol. Oncol. Res. 10 219-224